FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.44 $ 0.01 (0.23 %)    

Friday, 05-Jul-2024 09:43:11 EDT
QQQ $ 491.82 $ 0.08 (0.02 %)
DIA $ 393.32 $ 0.68 (0.17 %)
SPY $ 551.47 $ -0.32 (-0.06 %)
TLT $ 92.14 $ 0.06 (0.07 %)
GLD $ 220.04 $ 0.53 (0.24 %)
$ 4.23
$ 4.43
$ 0.00 x 0
$ 0.00 x 0
$ 4.43 - $ 4.45
$ 3.90 - $ 55.00
110,240
na
131.7M
$ -3.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...